Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
X.SuiX.et al (2023)
The introduction of oral formulations, such as oral semaglutide approved in 2019, has improved patient convenience and adherence by eliminating the need for injections
Considering the significantly elevated expression levels of GLP-1R in diabetic patients, it is hypothesized that administration of GLP-1R agonists may elevate the risk of breast cancer progression in these patients, thus necessitating particular caution in clinical management [101]
However, as the streptozotocin model primarily reflects severe insulin deficiency, the findings may not fully capture the complexity of type 2 diabetesrelated cognitive dysfunction
US$ 25.44
US$ 26.59
US$ 24.95
US$ 22.87
US$ 28.98
